Home Add to Favorite Contact Submit  
           29 March, 2024


    
Category:  Press » Legal

 

U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014

Popularity:
         Views: 4063
2009-09-24 04:34:37     
Eli Lilly and Company

The U.S. District Court for the Southern District of Indiana today upheld Eli Lilly and Company's (NYSE: LLY) method-of-use patents on Evista(R) (raloxifene HCl tablets). In the case of Eli Lilly and Company v. Teva Pharmaceuticals Industries Ltd., the court ruled in favor of Lilly on all accounts for these method-of-use patents, including the patent doctrines of obviousness, enablement, and inequitable conduct. These patents provide protection for Evista through March of 2014.

"We are pleased with the court's rulings on Evista's method-of-use patents. We have always been very confident that these patents are valid and enforceable and today's court ruling sends a clear message on the strength of those patents," said Robert A. Armitage, senior vice president and general counsel for Lilly. "Protection of intellectual property rights is extremely important to the biopharmaceutical industry and the physicians and patients we serve, as these rights help support the development of the next generation of innovative medicines to treat unmet medical needs."

In addition, the Court held Lilly's Evista particle-size patents invalid. The company is reviewing this aspect of the ruling to determine whether or not to appeal.

Evista is a breakthrough medicine indicated for the treatment and prevention of osteoporosis in postmenopausal women; and the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

Important Safety Information about EVISTA(R) (raloxifene HCl tablets)

Here are a few things you should know about EVISTA: EVISTA is not right for everyone. You should only take prescription EVISTA if you are past menopause. Before taking EVISTA, talk to your doctor about all your medical conditions.

You should not take EVISTA if you have had or are at risk for getting blood clots in the legs, lungs or eyes, as it may increase the risk of blood clots. Stop taking EVISTA and call your doctor if you have leg pain or warmth, swelling of the legs, hands or feet, chest pain, shortness of breath or a sudden vision change, as these may be signs of a blood clot. Being unable to move around for long periods may increase this risk. If you will need to be still for a long time, talk to your doctor about ways to reduce the risk of blood clots.

EVISTA does not increase the risk of a heart attack or stroke in women who have had or are at risk for a heart attack; however; EVISTA increases the likelihood of dying from stroke in these women, should one occur. Before taking EVISTA tell your doctor if you have had a stroke, a mini-stroke, irregular heartbeat, high blood pressure, heart attack, history of smoking, or believe you have other risk factors for stroke or a heart attack.

If you are pregnant, nursing or may become pregnant, do not take EVISTA, as it may cause fetal harm. Women with liver or kidney disease should use EVISTA with caution. EVISTA should not be taken with estrogens in the form of pills, patches or injections.

Side effects may include hot flashes, leg cramps, swelling, flu-like symptoms, joint pain, and sweating. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit website, or call 1-800-FDA-1088.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at website. C-LLY

This release contains forward-looking statements regarding the U.S. Evista patent litigation. These statements are based on management's current expectations but actual results may differ materially. There can be no assurance that the company will prevail in any appeal. Other risk factors that may affect the company results can be found in company's Form 10-Q dated July 2009 and Form 10-K dated February 2009.

Specialized in: Medwatch - Safety Information - Adverse Event Reporting
URL: http://www.fda.gov
Print press release      Bookmark this page
Related Press releases 
Fairfax Title Company Answers How Mortgage Refinancing Works (Popularity: ): Fairfax, Virginia (press.abc-directory.com) December 2, 2019 - Mathis Title Company, a Fairfax title company, recently published a blog called "How Mortgage Refinancing Works to help homeowners better understand the refinancing process. This can assist them in getting better refinancing deals and saving money for other investments.Mortgage refinancing is the process of replacing an existing mortgage with a new loan, often with a loan that offers lower monthly payments, lower interest ...
Two Happy Homes, Inc. Sponsors TDE - The Divorce Expo™ in Naperville (Popularity: ): Ann Arbor, MI, July 04, 2012 -- The first Metro Chicago The Divorce Expo™ will take place August 18 at the Hotel Arista, at CityGate Centre in Naperville. The expo is designed for those facing the challenges of divorce; whether they are considering divorce, currently living through a divorce or dealing with the aftermath. The event offers top experts in their fields, keynote speakers, 20 plus interactive seminars and demonstrations.“With ...
New Legal Advice Engine launched for Solicitors and Law Firms (Popularity: ): Legal question and answer company, Expert Answers Ltd, has launched its Online Legal Advice Engine for use by solicitors and law firms in the United Kingdom.Online legal advice specialist, Expert Answers Ltd, has announced the launch of its new Legal Advice Engine for solicitors and law firms in the UK. This engine will benefit solicitors and law firms in three ways:• an additional service to offer clients • revenue generation • source ...
Leading Atlanta Law Firm gets a New Web Presence (Popularity: ): MENLO PARK, CA -- December 10, 2012 - Martenson, Hasbrouck & Simon LLP, a leading Atlanta, GA, based law firm recently launched their redesigned website with a new look web presence designed by Flying Cow Design. The law firm's new website is designed to address the changing legal needs and connect with a growing web-savvy audience. The law firm is among the leading law firms in Atlanta, GA, specializing in ...
Law Office of Brodsky & Smith, LLC Announces Investigation of IntegraMed America, Inc. (Popularity: ): BALA CYNWYD, Pa., June 11, 2012 -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of IntegraMed America, Inc. ("IntegraMed" or the "Company") (Nasdaq: INMD) relating to the proposed acquisition by Sagard Capital Partners ("Sagard").Under the terms of the transaction, IntegraMed shareholders will receive $14.05 in cash for each share of IntegraMed stock they own. The investigation concerns possible ...


Related Business 
Minneapolis Bankruptcy (Popularity: ): Attorney James Whelpley was admitted to practice law in Minnesota in 1975, the Court of Military Appeals in 1976, the U.S. District Court, District of Minnesota in 1981 and the 8th Circuit Court of Appeals in 1982. Jim started out as a lawyer in the Marine Corps, handling both criminal and civil cases, and has handled a broad range of litigation in 30 years.
Sweet Lilly Maternity (Popularity: ): Sweet Lilly Maternity is Australia’s premier and favourite store for super stylish maternity clothes sourced from around the world. Particularly well known for best fitting maternity jeans, heavenly maternity bridal dresses and gorgeous maternity dresses, Sweet Lilly Maternity is THE place to shop for the best in maternity.
Patent Awards (Popularity: ): Recognition plaques and certificates for U.S. patents, trademarks, European patents, PCT publications, and foreign patents.
Bery, Janet - Reno Municipal Court, 2002 (Popularity: ): Judge Janet Berry has been a judge for over 10 years, first in Reno Municipal Court, and she has served in the Washoe County Second Judicial District Court, in which she is seeking a second term.
Legal Costs Consultants and Costing Services (Popularity: ): Pattison Hardman has been the recognized leader in legal costing services, legal rights and legal costs consultants in Sydney, NSW. We believe in providing quality legal costing services.Pattison Hardman has been retained to advise on multi-party, multi-cost orders and matters in the High Court of Australia, Federal Court of Australia, Administrative Appeals Tribunal, Family Court, Supreme Court of New South Wales, Land & Environment Court, District Court of New South ...
Eli Lilly Pharmaceutical (Popularity: ): Eli Lilly Ireland, specialising in women's health, depression and schizophrenia.
District Attorney General for the 30th District (Popularity: ): Serves Memphis and Shelby County. Annual report, a description of a community court pilot project, and explanations of office programs.
Ielectronics - Digital and Consumer Electronics (Popularity: ): Over 2,000 sq./m of showroom. Planning to open 2 new stores in 2013 and an additional 2 stores in 2014. Become a key player in this segment by the end of 2014. Capture 30% of market share by the end of 2014. With over 60 years of experience combined in our administration department, we know what it takes for us to strive in becoming leaders in the industry.
MDL-1355 Propulsid Product Liability Litigation (Popularity: ): Information on class action litigation relating to Propulsid, from the United States District Court for the Eastern District of Louisiana.
Rabin & Berdo, PC (Popularity: ): District of Columbia law firm, offering a downloadable brochure on mechanical and electrical patents.